Sequent Scientific completes acquisition of 40% stake in Provet

03 Nov 2020 Evaluate

Sequent Scientific has completed acquisition of 40% stake in Provet through Alivira Animal Health, Ireland,Wholly Owned Subsidiary of the Company. On completion of the said transaction, Provet has become a Wholly Owned Subsidiary of the Company.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals. Sequent is the world's largest producer of Anthelmintics and by far the strongest player in the Veterinary API business.

Viyash Scientific Share Price

207.35 6.05 (3.01%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×